Mesoblast (MESO) Total Debt (2018 - 2025)
Mesoblast (MESO) posted quarterly Total Debt of -$82.6 million for Q4 2025, down 116.89% year-on-year from $488.8 million in Q4 2024, and down 136.01% on a QoQ basis from $229.3 million in Q2 2025.
Mesoblast (MESO) Total Debt (2018 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Total Debt for 8 consecutive years, with -$82.6 million the latest figure, recorded in Q4 2025.
- Quarterly Total Debt fell 116.89% year-over-year to -$82.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$82.6 million (down 116.89% YoY) and the FY2025 annual result came in at $229.3 million, up 100.52% from the prior year.
- Total Debt eased to -$82.6 million in Q4 2025 per MESO's latest filing, from $229.3 million in the prior quarter.
- Over the last five years, Total Debt for MESO reached as high as $229.3 million in Q2 2025 and fell as low as -$82.6 million in Q4 2025.
- A 5-year average of $76.1 million and a median of $94.2 million in 2021 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt soared 341.66% — and 2024, when it slumped 141.53%.
- Year by year, Total Debt stood at $173.1 million in 2021, then sank by 110.82% to -$18.7 million in 2022, then grew by 15.85% to -$15.8 million in 2023, then sank by 141.53% to -$38.1 million in 2024, then tumbled by 116.89% to -$82.6 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered -$82.6 million, $229.3 million, and -$38.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | -82.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -82.58 Mn |
| Jun 30, 2025 | 229.29 Mn |
| Dec 31, 2024 | -38.07 Mn |
| Jun 30, 2024 | 114.35 Mn |
| Dec 31, 2023 | -15.76 Mn |
| Jun 30, 2023 | 108.76 Mn |
| Mar 31, 2023 | -20.02 Mn |
| Dec 31, 2022 | -18.73 Mn |
| Sep 30, 2022 | 188.37 Mn |
| Jun 30, 2022 | 96.63 Mn |
| Mar 31, 2022 | 177.29 Mn |
| Dec 31, 2021 | 173.08 Mn |
| Sep 30, 2021 | 42.65 Mn |
| Jun 30, 2021 | 94.25 Mn |
| Mar 31, 2021 | 92.52 Mn |
| Dec 31, 2020 | 98.17 Mn |
| Sep 30, 2020 | 112.20 Mn |
| Jun 30, 2020 | 114.05 Mn |
| Mar 31, 2020 | 119.90 Mn |
| Dec 31, 2019 | 131.99 Mn |